Skip to main content
Top

Cancer Immunology, Immunotherapy

Issue 6/2004

Content (11 Articles)

Opinion Paper

The effect of aging on cellular immunity against cancer in SR/CR mice

Zheng Cui, Mark C. Willingham

Original Article

Identification of new prostate stem cell antigen-derived peptides immunogenic in HLA-A2+ patients with hormone-refractory prostate cancer

Satoko Matsueda, Kazuhiko Kobayashi, Yoichi Nonaka, Masanori Noguchi, Kyogo Itoh, Mamoru Harada

Original Article

Ii-Key/HER-2/neu MHC class-II antigenic epitope vaccine peptide for breast cancer

Michael E. Gillogly, Nikoletta L. Kallinteris, Minzhen Xu, Joseph V. Gulfo, Robert E. Humphreys, James L. Murray

Original Article

A highly effective and stable bispecific diabody for cancer immunotherapy: cure of xenografted tumors by bispecific diabody and T-LAK cells

Hiroki Hayashi, Ryutaro Asano, Kouhei Tsumoto, Yu Katayose, Masanori Suzuki, Michiaki Unno, Hideaki Kodama, Shin-ichi Takemura, Hiroshi Yoshida, Koki Makabe, Kohzoh Imai, Seiki Matsuno, Izumi Kumagai, Toshio Kudo

Original Article

Dendritic cells are dysfunctional in patients with operable breast cancer

Sukchai Satthaporn, Adrian Robins, Wichai Vassanasiri, Mohamed El-Sheemy, Jibril A Jibril, David Clark, David Valerio, Oleg Eremin

Original Article

Rhabdomyosarcomas are potential target of MAGE-specific immunotherapies

Silvia Tanzarella, Ilaria Lionello, Barbara Valentinis, Vincenzo Russo, Pier-Luigi Lollini, Catia Traversari

Original Article

Biodistributions of intact monoclonal antibodies and fragments of BLCA-38, a new prostate cancer directed antibody

Teresa Carter, Katy Sterling-Levis, Kim Ow, Larissa Doughty, Meghan Hattarki, Deborah Shapira, Dean Hewish, Alexander A. Kortt, Pamela J. Russell

Original Article

Vascular endothelial growth factor inhibits maturation of dendritic cells induced by lipopolysaccharide, but not by proinflammatory cytokines

Akihiro Takahashi, Koji Kono, Fumiko Ichihara, Hidemitsu Sugai, Hideki Fujii, Yoshiro Matsumoto

Original Article

Down-regulation of HLA class II and costimulatory CD86/B7-2 on circulating monocytes from melanoma patients

Selma Ugurel, Dario Uhlig, Claudia Pföhler, Wolfgang Tilgen, Dirk Schadendorf, Uwe Reinhold

Short Communication

Detection of circulating tumor lysate–reactive CD4+ T cells in melanoma patients

Morten Ladekarl, Ralf Agger, Charlotte C. Fleischer, Marianne Hokland, Egil F. Hulgaard, Alexei Kirkin, Hans von der Maase, Mikkel S. Petersen, Carsten Rytter, Jesper Zeuthen, Hans Jørgen G. Gundersen

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine